American Society of Hirudotherapy

Variation in surgeon proficiency scores and association with digit replantation outcomes

Retrospective case series published in JAMA Netw Open (2021)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportClinical TrialsYoon AP et al. · JAMA network open, 2021

Abstract

IMPORTANCE: Risk-adjusted variation in surgeon outcomes has been traditionally explained by surgeon volume and hospital infrastructure, yet it is unclear how a surgeon's operative proficiency directly contributes to their patients' outcomes. OBJECTIVE: To assess the variation of surgeons' operative proficiency and investigate its association with surgical outcomes. DESIGN, SETTING, AND PARTICIPANTS: This case series was a retrospective analysis of all digit replantations and revascularizations at a single US university medical center between January 2000 and August 2020. Surgeons were assigned a proficiency score based on the expected procedure difficulty and outcomes from a sample of their cases. Surgeon proficiency scores were then used to determine associations with outcomes from subsequent cases. The expected difficulty of each case was calculated using a novel scoring system that applied pooled relative risks from a meta-analysis of risk factors for replantation and revascularization failure. EXPOSURES: Digit replantation and revascularization. MAIN OUTCOMES AND MEASURES: Digit survival at 1-month follow up (case success) and number of complications. RESULTS: A total of 145 patients and 226 digits were treated by 11 surgeons with training in hand or microsurgery (mean [SD] age, 41.9 [15.2] years; 204 [90%] men); there were 116 replantations and 110 revascularizations. Surgeon proficiency scores ranged from 1.3 to 5.7, with a mean (SD) of 3.4 (1.4). Case success rates among surgeons varied from 20.0% to 90.5%, with a mean (SD) of 64.9%. Higher proficiency scores were associated with fewer case failures: each point increase was associated with 40% decreased odds of failure (odds ratio, 0.60; 95% CI, 0.38-0.94). Every 3-point increase in proficiency score was associated with 1 less complication (effect estimate, -0.29; 95% CI, -0.56 to 0.02). Surgeon proficiency score had a greater association with case failure than surgeon volume (16.7% vs 12.0%). The final model's association with case failure had an area under the receiver operating characteristics curve of 0.93. CONCLUSIONS AND RELEVANCE: Operative proficiency varied widely among practicing surgeons and accounted for 17% of estimative ability for success of digit replantation and revascularization. Greater surgeon proficiency was associated with better outcomes, indicating that the value of surgical care may be optimized by improving surgeon proficiency.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAdultAmputation, SurgicalClinical CompetenceFemaleFingersHumansLogistic ModelsMaleMiddle AgedOdds RatioPropensity ScoreReplantation

Summary

Retrospective analysis of 226 digits across 11 surgeons showing wide proficiency variation (1.3-5.7 score range) with significant association between proficiency and case success (OR 0.60 per point).

Why This Matters for Hirudotherapy

This retrospective case series analyzed 145 patients (226 digits) treated by 11 surgeons at a single US medical center, finding that higher surgeon proficiency scores were associated with 40% decreased odds of case failure in digit replantation and revascularization. Surgeon proficiency had a greater association with case failure than surgeon volume. The study makes no mention of leech therapy, hirudotherapy, or venous congestion management. There is no defensible leech-related relevance to ASH's domain in this article, which focuses entirely on surgical skill assessment and outcomes prediction in digit replantation.

Citation

Variation in surgeon proficiency scores and association with digit replantation outcomes.

Yoon AP et al. · JAMA network open, 2021

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.